Happy to share our latest work on uveal melanoma!
Huge thanks to @ESaldanhaMD and @mauriciofribei1 great collaboration.
Check out our perspective from @pmcancercentre published in @ESMO_Open
📌Happy to share our perspective on uveal melanoma management, just out in @ESMO_Open
With this amazing team @mauriciofribei1 @IanHirsch3
🔗 esmoopen.com/article/S2059-7…
7
335
1/
Large Language Models (LLMs) contain extensive medical knowledge despite not being specifically trained for it; but, their performance on standardized tests across various subspecialties is inconsistent.
5/
Overall, our findings suggest LLMs hold promise for enhancing healthcare, but they require rigorous testing and oversight to ensure safety. The future of AI in medicine is bright but must be navigated with caution.
1
103
6/
This has been a collaborative effort of the @ml4onc group.
Thank you @pmcancercentre , the @thePMCF and @PM_CDI for their support.
96
Just out in @JCO_ASCO
Work by @KevinJCHe et al.
Machine Learning to allocate palliative care consults!
1/
Palliative care (PC) can significantly improve outcomes for advanced cancer patients. But limited capacity often delays or prevents access. Our latest study from Ontario, 🇨🇦, explores using machine learning to address this gap. @JCO_ASCO ascopubs.org/doi/10.1200/JCO…
250
Just out!
Important step towards resource optimization.
Amazing work from Dr. Grant and the ML4O team
New paper out in @JCO_ASCO!
Fantastic effort by Kevin and the team.
Using @ICESOntario data, we show how machine learning could benefit patients through early palliative care.
Thanks to @thePMCF and @OICR_news for their support!
ascopubs.org/doi/10.1200/JCO…
2
305
Argentina currently spends just 0.5% of its GDP on R&D, which is low even by the standards of some middle-income countries . That is what Argentina should aspire to. The nation’s leaders need to work closely with scientists and tap into their knowledge and skills. – at Toronto, Ontario
Cutting health and science support should not be an option in Argentina’s election.
As the nation chooses its next president, citizens must consider the wider benefits of research investment — long-term prosperity, well-being and growth go.nature.com/49mzecZ
Ian Hirsch retweeted
En este momento quedarse callado es ser cómplice.
La ultraderecha aplasta minorías y nos niega como individuos en pos de un plan económico que beneficia a un sector reducido de la sociedad.
Entiendo la bronca por la situación de Argentina pero Milei NO es la salida.
Ian Hirsch retweeted
Very delighted to have been selected for the ASCO Education Scholars Program. Thank you @ConquerCancerFd for this opportunity!
Ian Hirsch retweeted
This article summarises ongoing immune checkpoint inhibitor optimisation trials. Establishing optimised immune checkpoint inhibitor protocols will be challenging, but is a necessary step toward global access. @OCCA_Cancer @MRCCTU nature.com/articles/s41591-0…
Please join us in reading out latest publication in @NatureMedicine, discussing dose optimization for ICI to allow global access.
Thank you to all the co-authors for their guidance: Dr. Gilbert, @MarcusButler_PM, @drdgoldstein and Dr. Tannock
nature.com/articles/s41591-0…
Just out!
Our most recent systematic review on Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials.
@fwaisberg1 @PabloMando @DrClaudiomartin @aaoncoclinica
@Andrwrodri84 authors.elsevier.com/c/1fGX2… – at Toronto, Ontario
Congratulations @mauriciofribei1 on your presentation at @CAMO_ACOM regarding technology access to elderly patients diagnosed with melanoma.
Do Brasil pro mundo!
"These 3 heroic attributes of individualism, sacrifice, and stoic endurance can actually undermine the system transformation needed in health care."
Interesante perspectiva para los cambios que hacen falta.
ja.ma/35dJtR1 via @JAMA_current part of @JAMANetwork
Ian Hirsch retweeted
Después de haber votado 5 a 0 en contra de la aprobación de la vacuna Sputnik V hace poco más de un mes, los mismos 5 de ANVISA en Brasil –con los mismos datos– votaron hoy 4 a 1 a favor de aprobar su uso. reuters.com/world/americas/b…















